Source: Journal of rheumatology. Unidade: FM
Subjects: DOENÇAS REUMÁTICAS (IMUNOLOGIA), ADOLESCENTES, IMUNOGENÉTICA, AUTOIMUNIDADE, INFLAMAÇÃO, VACINAS, INFLUENZA (IMUNOLOGIA)
ABNT
AIKAWA, Nadia E. et al. Glucocorticoid: Major Factor for Reduced Immunogenicity of 2009 Influenza A (H1N1) Vaccine in Patients with Juvenile Autoimmune Rheumatic Disease. Journal of rheumatology, v. 39, n. 1, p. 167-173, 2012Tradução . . Disponível em: https://doi.org/10.3899/jrheum.110721. Acesso em: 31 out. 2024.APA
Aikawa, N. E., Campos, L. M. A., Silva, C. A., Carvalho, J. F., Saad, C. G. S., Trudes, G., et al. (2012). Glucocorticoid: Major Factor for Reduced Immunogenicity of 2009 Influenza A (H1N1) Vaccine in Patients with Juvenile Autoimmune Rheumatic Disease. Journal of rheumatology, 39( 1), 167-173. doi:10.3899/jrheum.110721NLM
Aikawa NE, Campos LMA, Silva CA, Carvalho JF, Saad CGS, Trudes G, Duarte A, Miraglia JL, Timenetsky M do CS, Viana VST, França ILA, Bonfa E, Pereira RMR. Glucocorticoid: Major Factor for Reduced Immunogenicity of 2009 Influenza A (H1N1) Vaccine in Patients with Juvenile Autoimmune Rheumatic Disease [Internet]. Journal of rheumatology. 2012 ; 39( 1): 167-173.[citado 2024 out. 31 ] Available from: https://doi.org/10.3899/jrheum.110721Vancouver
Aikawa NE, Campos LMA, Silva CA, Carvalho JF, Saad CGS, Trudes G, Duarte A, Miraglia JL, Timenetsky M do CS, Viana VST, França ILA, Bonfa E, Pereira RMR. Glucocorticoid: Major Factor for Reduced Immunogenicity of 2009 Influenza A (H1N1) Vaccine in Patients with Juvenile Autoimmune Rheumatic Disease [Internet]. Journal of rheumatology. 2012 ; 39( 1): 167-173.[citado 2024 out. 31 ] Available from: https://doi.org/10.3899/jrheum.110721